These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16871494)

  • 1. Clinical effectiveness and safety of a new NSAID, firocoxib: a 1,000 dog study.
    Ryan WG; Moldave K; Carithers D
    Vet Ther; 2006; 7(2):119-26. PubMed ID: 16871494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy and safety of firocoxib in the treatment of dogs with osteoarthritis.
    Autefage A; Palissier FM; Asimus E; Pepin-Richard C
    Vet Rec; 2011 Jun; 168(23):617. PubMed ID: 21642297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of firocoxib in the management of canine osteoarthritis under field conditions.
    Hanson PD; Brooks KC; Case J; Conzemius M; Gordon W; Schuessler J; Shelley B; Sifferman R; Drag M; Alva R; Bell L; Romano D; Fleishman C
    Vet Ther; 2006; 7(2):127-40. PubMed ID: 16871495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance of firocoxib in dogs with osteoarthritis during 90 days.
    Lecoindre O; Pepin-Richard C
    J Vet Pharmacol Ther; 2011 Apr; 34(2):190-2. PubMed ID: 21395612
    [No Abstract]   [Full Text] [Related]  

  • 5. Switching NSAIDs in practice: insights from the Previcox (firocoxib) Experience Trial.
    Ryan WG; Moldave K; Carithers D
    Vet Ther; 2007; 8(4):263-71. PubMed ID: 18183545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of oral administration of firocoxib for the management of musculoskeletal pain and lameness associated with osteoarthritis in horses.
    Orsini JA; Ryan WG; Carithers DS; Boston RC
    Am J Vet Res; 2012 May; 73(5):664-71. PubMed ID: 22533398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of firocoxib and carprofen for the treatment of dogs with osteoarthritis.
    Pollmeier M; Toulemonde C; Fleishman C; Hanson PD
    Vet Rec; 2006 Oct; 159(17):547-51. PubMed ID: 17056650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of firocoxib (Previcox) in geriatric dogs over a period of 90 days.
    Joubert KE
    J S Afr Vet Assoc; 2009 Sep; 80(3):179-84. PubMed ID: 20169752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis.
    Doucet MY; Bertone AL; Hendrickson D; Hughes F; Macallister C; McClure S; Reinemeyer C; Rossier Y; Sifferman R; Vrins AA; White G; Kunkle B; Alva R; Romano D; Hanson PD
    J Am Vet Med Assoc; 2008 Jan; 232(1):91-7. PubMed ID: 18167116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis.
    Vijarnsorn M; Kwananocha I; Kashemsant N; Jarudecha T; Lekcharoensuk C; Beale B; Peirone B; Lascelles BDX
    BMC Vet Res; 2019 Oct; 15(1):349. PubMed ID: 31623621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs.
    de Salazar Alcalá AG; Gioda L; Dehman A; Beugnet F
    BMC Vet Res; 2019 Aug; 15(1):309. PubMed ID: 31464629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder.
    Knapp DW; Henry CJ; Widmer WR; Tan KM; Moore GE; Ramos-Vara JA; Lucroy MD; Greenberg CB; Greene SN; Abbo AH; Hanson PD; Alva R; Bonney PL
    J Vet Intern Med; 2013; 27(1):126-33. PubMed ID: 23205923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of firocoxib and tepoxalin on healing in a canine gastric mucosal injury model.
    Goodman L; Torres B; Punke J; Reynolds L; Speas A; Ellis A; Budsberg S
    J Vet Intern Med; 2009; 23(1):56-62. PubMed ID: 19175721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of firocoxib, meloxicam, and tepoxalin on prostanoid and leukotriene production by duodenal mucosa and other tissues of osteoarthritic dogs.
    Punke JP; Speas AL; Reynolds LR; Budsberg SC
    Am J Vet Res; 2008 Sep; 69(9):1203-9. PubMed ID: 18764695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of the safety and efficacy of long-term NSAID use in the treatment of canine osteoarthritis.
    Innes JF; Clayton J; Lascelles BD
    Vet Rec; 2010 Feb; 166(8):226-30. PubMed ID: 20173106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vesiculobullous skin reaction temporally related to firocoxib treatment in a white rhinoceros (Ceratotherium simum).
    Stringer EM; De Voe RS; Linder K; Troan B; McCalla-Martin A; Loomis MR
    J Zoo Wildl Med; 2012 Mar; 43(1):186-9. PubMed ID: 22448531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous adverse drug reaction in a dog following firocoxib treatment.
    Geum M; Ko HY; Na YJ; Kim HJ
    Vet Med Sci; 2021 Sep; 7(5):1504-1508. PubMed ID: 34021731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The attitudes of owners and veterinary professionals in the United Kingdom to the risk of adverse events associated with using non-steroidal anti-inflammatory drugs (NSAIDs) to treat dogs with osteoarthritis.
    Belshaw Z; Asher L; Dean RS
    Prev Vet Med; 2016 Sep; 131():121-126. PubMed ID: 27544261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of the homeopathic preparation Zeel compared with carprofen in dogs with osteoarthritis.
    Neumann S; Stolt P; Braun G; Hellmann K; Reinhart E
    J Am Anim Hosp Assoc; 2011; 47(1):12-20. PubMed ID: 21164168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [European symposium about osteoarthritis in a dog].
    Overgaauw P
    Tijdschr Diergeneeskd; 2007 Jan; 132(1):978-9. PubMed ID: 17334108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.